Новости компании

Avifavir® is effective against various variants of coronavirus, including Delta and Omicron, as it affects the highly ...
27.12.2021
Avifavir® is the first product approved in Russia for treatment of coronavirus and the world-first registered product ...
03.12.2021
Chromis, a joint venture of the Russian Direct Investment Fund (RDIF) and ChemRar Group, was rated by Rospatent among ...
17.06.2021
Ajax Call Form
Loading...